JPH01503777A - 縮合脂環式アミノアルコール類 - Google Patents

縮合脂環式アミノアルコール類

Info

Publication number
JPH01503777A
JPH01503777A JP61505852A JP50585286A JPH01503777A JP H01503777 A JPH01503777 A JP H01503777A JP 61505852 A JP61505852 A JP 61505852A JP 50585286 A JP50585286 A JP 50585286A JP H01503777 A JPH01503777 A JP H01503777A
Authority
JP
Japan
Prior art keywords
tables
formulas
formula
chemical formulas
mathematical formulas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61505852A
Other languages
English (en)
Japanese (ja)
Inventor
ピツチヨーラ，ジヤンパオロ
リバ，マリオ
ラベンナ，フランコ
ジエンテイーリ，ピエルジヨルジヨ
Original Assignee
マツジヨ‐ニ‐ウインスロツプ・ソチエタ・ペル・アチオニ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524491A external-priority patent/GB8524491D0/en
Priority claimed from GB868615560A external-priority patent/GB8615560D0/en
Application filed by マツジヨ‐ニ‐ウインスロツプ・ソチエタ・ペル・アチオニ filed Critical マツジヨ‐ニ‐ウインスロツプ・ソチエタ・ペル・アチオニ
Publication of JPH01503777A publication Critical patent/JPH01503777A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
JP61505852A 1985-10-04 1986-09-29 縮合脂環式アミノアルコール類 Pending JPH01503777A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB858524491A GB8524491D0 (en) 1985-10-04 1985-10-04 Fused cycloaliphatic aminoalcohols
GB8524491 1985-10-04
GB8615560 1986-06-25
GB868615560A GB8615560D0 (en) 1986-06-25 1986-06-25 Aminoalcohols

Publications (1)

Publication Number Publication Date
JPH01503777A true JPH01503777A (ja) 1989-12-21

Family

ID=26289843

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61505852A Pending JPH01503777A (ja) 1985-10-04 1986-09-29 縮合脂環式アミノアルコール類

Country Status (6)

Country Link
JP (1) JPH01503777A (da)
KR (1) KR870700595A (da)
AU (1) AU6548286A (da)
DK (1) DK281187A (da)
GR (1) GR862492B (da)
WO (1) WO1987002035A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1331191C (en) * 1988-03-25 1994-08-02 Bengt Ronny Andersson Therapeutically useful tetralin derivatives
IL93464A (en) * 1989-02-27 1996-10-16 Lilly Co Eli 2-Amino-1,2,3,4-Tetrahydronaplanin and 3 aminochromes with a transformed ring, a process for their preparation and pharmaceutical preparations containing them
US5457121A (en) * 1994-09-02 1995-10-10 Eli Lilly And Company Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,4-c>pyrroles as inhibitors of serotonin reuptake
FR2769312B1 (fr) * 1997-10-03 1999-12-03 Adir Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE10142666A1 (de) * 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
BRPI0518841A2 (pt) * 2004-12-07 2008-12-09 Glaxo Group Ltd derivados de indenila e uso destes para o tratamento de transtornos neurolàgicos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2549685A (en) * 1948-09-30 1951-04-17 Upjohn Co Dioxy substituted 2-aminoindanols
FR1360532A (fr) * 1962-06-13 1964-05-08 Res Lab Dr C Janssen Nv Procédé de production de dérivés de la benzimidazolone et de leurs sels d'addition avec des acides
JPS561305B2 (da) * 1972-12-18 1981-01-13
JPS50151853A (da) * 1974-05-20 1975-12-06
US4018773A (en) * 1975-09-15 1977-04-19 E. R. Squibb & Sons, Inc. Phenylpiperazinotetrahydronaphthols and derivatives
FI68821C (fi) * 1977-07-18 1985-11-11 Sandoz Ag Analogifoerfarande foer framstaellning av nya tetralinderivat vilka saenker blodtryck och oekar blodetsgenomstroemning
US4189484A (en) * 1977-11-08 1980-02-19 Mitsubishi Yuka Pharmaceutical Co., Ltd. Antihypertensive quinazoline derivatives
US4533745A (en) * 1980-12-08 1985-08-06 Merck & Co., Inc. Amino ketones and their preparation

Also Published As

Publication number Publication date
WO1987002035A1 (en) 1987-04-09
DK281187D0 (da) 1987-06-02
AU6548286A (en) 1987-04-24
DK281187A (da) 1987-06-02
KR870700595A (ko) 1987-12-30
GR862492B (en) 1987-02-03

Similar Documents

Publication Publication Date Title
US5324733A (en) Spirocyclic antipsychotic agents
AU653245B2 (en) Novel benzopyran derivatives
EP0028381B1 (en) Azepinoindoles, process for their production and pharmaceutical compositions containing them
JPS5943957B2 (ja) 新規なジベンゾピラン類
NZ197582A (en) Dextrorotatory trans-4a,9b-5phenyl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3-b) indoles
US4529724A (en) 6H-indolo[2,1-c][1,4]benzodiazepines and 12-oxo derivatives useful as antihypertensives
JPH0570457A (ja) 置換イミダゾール−２−オンの誘導体及びその製造方法
JPH089580B2 (ja) アミノアルコ−ル、その製造法およびその用途
GB1569251A (en) Pyridobenzodiazepines
US3557127A (en) Substituted cyclohexenes,derivatives thereof and processes for obtaining same
AU736710B2 (en) New indanol compounds, a process for their preparation and pharmaceutical compositions containing them
US5096900A (en) (4-piperidyl)methyl-2,3-dihydro-1h-isoindole and -2,3,4,5-tetrahydro-1h-benzazepine derivatives, their preparation and their application in therapy
JPH0559117B2 (da)
WO1987002035A1 (en) Fused cycloaliphatic aminoalcohols
CZ286649B6 (cs) 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano-/2,3-e/indol-8-onové deriváty a farmaceutický prostředek s jejich obsahem
JPH03120271A (ja) 抗虚血活性を有するフェニルアルキルアミン誘導体
US4927819A (en) Cyclo-octane neuroprotective agents
JPH037280A (ja) 新規ベンゾチオピラニルアミン
US4287211A (en) Derivatives of phenylethylamines, processes for their preparation and related pharmaceutical compositions
JPS6028838B2 (ja) 窒素含有多環化合物の製造方法
JPH0474354B2 (da)
US3703523A (en) Tropanol esters of alpha-phenyl-alpha-cyclopentyl-acetic acid
US4757079A (en) Anti-hypertensive piperidine compounds
JPS5910359B2 (ja) シンキナチツソガンユウタカンカゴウブツ ノ チヨウセイホウホウ
JPH02200685A (ja) 新規なインドール誘導体